mhurhangee/ep-ind-claims huggingface dataset:
A method for at least partially emptying an extracorporeal blood circulation after the patient's blood in the extracorporeal blood circulation has been returned to the patient with the help of an infusion fluid for displacing the blood, and the patient has been disconnected from the extracorporeal blood circulation, wherein the extracorporeal circulation has an arterial blood line leading from an arterial connection location (13, 14) to the blood chamber of a hemodialyzer, which is divided by a semipermeable membrane into a blood chamber and a dialysis fluid chamber, also having the blood chamber of the hemodialyser and a venous blood line leading from the blood chamber to a venous connection location (15, 16), wherein without additionally connecting the arterial and venous blood lines to one another, the arterial blood line is actively or passively ventilated at a first location, and the venous blood line is actively or passively ventilated at a second location, and the fluid in the blood chamber of the hemodialyser as well as in the section of the arterial blood line between the blood chamber and the first location and in the section of the venous blood line between the blood chamber and the second location is emptied through the semipermeable membrane into the dialysis fluid chamber and a dialysis fluid discharge line leaving this chamber.
Profile rail system which has at least one base rail and at least one top rail held thereon, wherein the at least one top rail has at least one covering wing, for covering at least one edge of a covering, and webs, and the at least one base rail has webs which are embraced by the webs of the top rail, and the webs of the base rail can grasp the webs of the at least one top rail, and the webs (7, 8) have latching means, and the mutual distance between the webs of the base rail - as viewed in cross section - is enlarged over their length in order to be able to pivot the at least one top rail, characterized in that at least one protrusion is integrally formed on the inside of at least one of the webs of the base rail, the protrusion being remote from the latching means of the webs (7, 8) and running obliquely upwards and at which the at least one web can be grasped in order to undo a latching between the latching means and to be able to remove the at least one top rail.
A polyurethane foam composition comprising at least one propellant and a polyurethane prepolymer composition based on polyisocyanates which comprise, based on the weight of the polyisocyanates, at least 20 wt% methyl diphenyl diisocyanate monomer and at most 24.5 wt% of toluene diisocyanate monomer, at least one towards isocyanate polyfunctional reactive compound and at least one towards isocyanate monofunctional reactive compound, the foam composition a) containing less than 1.00 wt% of residual free methyl diphenyl diisocyanate monomer, b) containing at least 0.4 wt% total of methyl diphenyl diisocyanate monomers of which at least one of the two isocyanate functional groups has been reacted with a towards isocyanate monofunctional reactive compound, c) wherein the polyurethane prepolymer composition is having an isocyanate index, expressed relative to all the towards isocyanate reactive functional groups involved in forming the polyurethane prepolymer composition, of at least 105 and at most 350, d) wherein the equivalents ratio of the towards isocyanate monofunctional reactive compounds relative to the amount of the isocyanate functional groups initially present is at least 6.5 %, and e) wherein the equivalents ratio of towards isocyanate tri- and higher functional reactive compounds relative to the amount of the isocyanate functional groups initially present is at most 6.50 %, whereby the concentrations, unless stated otherwise, are expressed relative to the total weight of the foam composition. a) containing less than 1.00 wt% of residual free methyl diphenyl diisocyanate monomer, b) containing at least 0.4 wt% total of methyl diphenyl diisocyanate monomers of which at least one of the two isocyanate functional groups has been reacted with a towards isocyanate monofunctional reactive compound, c) wherein the polyurethane prepolymer composition is having an isocyanate index, expressed relative to all the towards isocyanate reactive functional groups involved in forming the polyurethane prepolymer composition, of at least 105 and at most 350, d) wherein the equivalents ratio of the towards isocyanate monofunctional reactive compounds relative to the amount of the isocyanate functional groups initially present is at least 6.5 %, and e) wherein the equivalents ratio of towards isocyanate tri- and higher functional reactive compounds relative to the amount of the isocyanate functional groups initially present is at most 6.50 %,
A chromogenic conjugate comprising: (a) a chromogenic moiety, and (b) a peroxidase substrate moiety, wherein the chromogenic moiety and the peroxidase substrate moiety are linked together via a linker, wherein the linker is a water soluble molecular moiety, and wherein the conjugate is a compound of Formula I: where X is -OH, -OR X or -NR X R XX, where Y is =O or =N + R Y R YY; wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, R 10, R X, R xx, R Y, and R YY are independently selected from hydrogen and a substituent having less than 40 atoms; L is a linker comprising a linear chain of 5 to 29 consecutively connected atoms, wherein L is linked to a rhodamine, fluorescein, or rhodamine or fluorescein derivative moiety through an ester or amide linkage; and wherein R 21 is -H, R 22 is -H, -O-X, or -N 2; R 23 is -OH; R 21 is -H, -O-X, or -N 2; R 25 is - H, -O-X, or -N 2; R 21 is -CON- 2, -CONH, or -COO; wherein H is hydrogen; O is oxygen; N is nitrogen; and X is H, alkyl or aryl. (a) a chromogenic moiety, and (b) a peroxidase substrate moiety, wherein the chromogenic moiety and the peroxidase substrate moiety are linked together via a linker, wherein the linker is a water soluble molecular moiety, and wherein the conjugate is a compound of Formula I: where X is -OH, -OR X or -NR X R XX, where Y is =O or =N + R Y R YY; wherein R 1, R 2, R 3, R 4, R 5, R 6, R 7, R 8, R 9, R 10, R X, R xx, R Y, and R YY are independently selected from hydrogen and a substituent having less than 40 atoms; L is a linker comprising a linear chain of 5 to 29 consecutively connected atoms, wherein L is linked to a rhodamine, fluorescein, or rhodamine or fluorescein derivative moiety through an ester or amide linkage; and wherein R 21 is -H, R 22 is -H, -O-X, or -N 2; R 23 is -OH; R 21 is -H, -O-X, or -N 2; R 25 is - H, -O-X, or -N 2; R 21 is -CON- 2, -CONH, or -COO; R 21 is -H, R 22 is -H, -O-X, or -N 2; R 23 is -OH; R 21 is -H, -O-X, or -N 2; R 25 is - H, -O-X, or -N 2; R 21 is -CON- 2, -CONH, or -COO; wherein H is hydrogen; O is oxygen; N is nitrogen; and X is H, alkyl or aryl.
A box-type package with a lid that opens like a casket, designed to contain foodstuff products, in particular confectionery products, said package comprising: - a paperboard casing defining a base and a lid connected to said base so as to be able to oscillate between a position of opening and a position of closing of said package; and - a support made of polymeric material defining a plurality of cells designed to receive said products, which is carried by said base wherein, said base of said casing comprises a bottom and at least one tab, which can be folded with respect to said bottom, and in that said support, which is set on said bottom, comprises at the bottom a slot, within which said at least one tab is inserted, for connecting said support to said casing in a configuration in which said support defines at least top portions of the outer side walls of the container of said box-like package, and in that said support comprises a tray portion, identified on which are said cells, and a side wall that surrounds said tray portion and delimits the top surface of said tray portion laterally, in which said side wall has a flap folded out downwards so as to set itself opposed to the non-folded part of said wall and form said slot, said slot extending along the entire perimeter of said support. - a paperboard casing defining a base and a lid connected to said base so as to be able to oscillate between a position of opening and a position of closing of said package; and - a support made of polymeric material defining a plurality of cells designed to receive said products, which is carried by said base wherein, said base of said casing comprises a bottom and at least one tab, which can be folded with respect to said bottom, and in that said support, which is set on said bottom, comprises at the bottom a slot, within which said at least one tab is inserted, for connecting said support to said casing in a configuration in which said support defines at least top portions of the outer side walls of the container of said box-like package, and in that said support comprises a tray portion, identified on which are said cells, and a side wall that surrounds said tray portion and delimits the top surface of said tray portion laterally, in which said side wall has a flap folded out downwards so as to set itself opposed to the non-folded part of said wall and form said slot, said slot extending along the entire perimeter of said support.
Use of one or both of: an acid-beta-glucocerebrosidase polypeptide and a polynucleotide encoding an acid-beta-glucocerebrosidase polypeptide, in the preparation of a medicament for use in a method of treating a subject with a synucleinopathy, but not a clinically diagnosed lysosomal storage disease, wherein the polypeptide or polynucleotide is administered in an amount effective to reduce a level of α-synuclein in the subject's central or peripheral nervous system, or both, or in the subject's lysosomal compartment. an acid-beta-glucocerebrosidase polypeptide and a polynucleotide encoding an acid-beta-glucocerebrosidase polypeptide, in the preparation of a medicament for use in a method of treating a subject with a synucleinopathy, but not a clinically diagnosed lysosomal storage disease, wherein the polypeptide or polynucleotide is administered in an amount effective to reduce a level of α-synuclein in the subject's central or peripheral nervous system, or both, or in the subject's lysosomal compartment.
An electrically conductive sheet for use in three-dimensional molding, the electrically conductive sheet comprising: a pseudo-sheet structure in which a plurality of electrically conductive linear bodies extending unidirectionally are arranged spaced apart from each other, wherein each of the electrically conductive linear bodies includes: a first portion (22A; 22AA) formed in a wave pattern having a wavelength λ1 and an amplitude A1; and a second portion (22B; 22BB) formed in a wave pattern having a wavelength λ2 and an amplitude A2, at least one of which is different from the wavelength λ1 or the amplitude A1 of the first portion; and a resin protective layer provided at a side of one surface of the pseudo-sheet structure, characterized in that the electrically conductive linear bodies are arranged such that adjacent electrically conductive linear bodies are regularly spaced apart from each other, the interval between adjacent electrically conductive linear bodies is from 0.3 mm to 12.0 mm. a pseudo-sheet structure in which a plurality of electrically conductive linear bodies extending unidirectionally are arranged spaced apart from each other, wherein each of the electrically conductive linear bodies includes: a first portion (22A; 22AA) formed in a wave pattern having a wavelength λ1 and an amplitude A1; and a second portion (22B; 22BB) formed in a wave pattern having a wavelength λ2 and an amplitude A2, at least one of which is different from the wavelength λ1 or the amplitude A1 of the first portion; and a first portion (22A; 22AA) formed in a wave pattern having a wavelength λ1 and an amplitude A1; and a second portion (22B; 22BB) formed in a wave pattern having a wavelength λ2 and an amplitude A2, at least one of which is different from the wavelength λ1 or the amplitude A1 of the first portion; and a resin protective layer provided at a side of one surface of the pseudo-sheet structure, characterized in that the electrically conductive linear bodies are arranged such that adjacent electrically conductive linear bodies are regularly spaced apart from each other, the interval between adjacent electrically conductive linear bodies is from 0.3 mm to 12.0 mm.
A method of servicing content for delivery to a client device, said method comprising: identifying a type of service to be performed on an item of content, wherein said item of content is identified during a session involving said client device; selecting a provider from a plurality of providers capable of performing said service, said selecting comprising maintaining a record of providers to which sessions have been transferred; selecting said provider according to said record; estimating an amount of time said session is expected to remain with said provider, and updating said record once said amount of time has passed; and providing information for transferring said session to said provider, wherein said provider performs said service on said item of content. identifying a type of service to be performed on an item of content, wherein said item of content is identified during a session involving said client device; selecting a provider from a plurality of providers capable of performing said service, said selecting comprising maintaining a record of providers to which sessions have been transferred; selecting said provider according to said record; estimating an amount of time said session is expected to remain with said provider, and updating said record once said amount of time has passed; and providing information for transferring said session to said provider, wherein said provider performs said service on said item of content.
A polymer composition containing a polymer matrix and one or more fillers, wherein at least one filler contains the insoluble digestion residue which precipitates out during digestion of a titanium-containing starting material or which is produced therefrom, wherein the polymer of the polymer matrix is selected from thermoplastic elastomers or mixtures thereof, and wherein the digestion residue precipitates out during the production of titanium dioxide during digestion of a titanium-containing starting material with sulphuric acid in accordance with the sulphate process.
A real time closed loop brain-machine interface comprising: a) a plurality of electrodes adapted to be chronically implanted into the brain of a subject and to acquire extracellular electrical signals from a population of single neurons directly from the brain of the subject; b) a signal processing mechanism adapted to communicate with the plurality of electrodes and adapted to form extracted motor commands from the extracellular electrical signals; and c) an actuator (40, 45) adapted to communicate with the signal processing mechanism and to respond to the extracted motor commands by effecting a movement, and to provide sensory feedback as electrical signals directly to the brain of the subject. a) a plurality of electrodes adapted to be chronically implanted into the brain of a subject and to acquire extracellular electrical signals from a population of single neurons directly from the brain of the subject; b) a signal processing mechanism adapted to communicate with the plurality of electrodes and adapted to form extracted motor commands from the extracellular electrical signals; and c) an actuator (40, 45) adapted to communicate with the signal processing mechanism and to respond to the extracted motor commands by effecting a movement, and to provide sensory feedback as electrical signals directly to the brain of the subject.
A method of evolution and expression of an antibody in an eukaryotic cell production host; the method comprising: a. selecting a template antibody; b. evolving the template antibody to enable production of a set of mutant antibodies in the host using eukaryotic cell surface display of the mutant antibodies; c. screening the mutant antibodies for at least one predetermined property, characteristic or activity; d. selecting an up-mutant antibody from the set of mutant antibodies based upon optimization of the at least one predetermined property, characteristic or activity as compared to a same property, characteristic or activity of the template antibody; and e. expressing the up-mutant antibody in the same host as in step b. a. selecting a template antibody; b. evolving the template antibody to enable production of a set of mutant antibodies in the host using eukaryotic cell surface display of the mutant antibodies; c. screening the mutant antibodies for at least one predetermined property, characteristic or activity; d. selecting an up-mutant antibody from the set of mutant antibodies based upon optimization of the at least one predetermined property, characteristic or activity as compared to a same property, characteristic or activity of the template antibody; and e. expressing the up-mutant antibody in the same host as in step b.
Floor cleaning machine, comprising a chassis, at least one floor processing tool apparatus (166; 60; 168), which holds at least one floor processing tool, and a fixing device for releasably mounting the at least one floor processing tool apparatus on the chassis, with a first fixing device (112; 112'), which is arranged on the at least one floor processing tool apparatus, and with a second fixing device, which is arranged on the chassis, wherein the first fixing device (112; 112') and the second fixing device are adapted to one another, the first fixing device (112; 112') comprises a first abutment region (116; 116') and a second abutment region (124; 124'), the second fixing device comprises a third abutment region for the first abutment region (116; 116') and a fourth abutment region for the second abutment region (124; 124'), and the fixing device has a clamping device (144; 164) for clamping the at least one floor processing tool apparatus to the chassis, wherein the first abutment region (116; 116') and the second abutment region (124; 124') are located opposite one another and face away from one another, and in that the third abutment region and the fourth abutment region are located opposite one another and face toward one another, characterized in that the fourth abutment region is configured as a support region for the at least one floor processing tool apparatus and forms a lower support face in relation to the direction of gravity, and in that the third abutment region and the fourth abutment region are arranged on a transverse support and/or on one or more longitudinal supports (122a, 122b) of the chassis.
A method for producing lamination stacks comprising the steps of: pushing a metal strip into a blanking station; and blanking said metal strip in said blanking station to produce a first blanked lamination by means of a press; moving said first blanked lamination in a direction transverse to the direction of supply of said metal strip into a gluing station (25, 26), outside said blanking station; pushing said metal strip into said blanking station; and setting said first lamination in an area for collection and formation of lamination stacks; said method being characterized in that it comprises the steps of blanking said metal strip in said blanking station to produce a second blanked lamination and simultaneously spraying the glue on at least one area provided on said first blanked lamination; using said press that comprises at the centre a punch and alongside the latter two glue dispensers and; locating underneath the punch the blanking station, where the metal strip to be blanked" is positioned; positioning corresponding to the two glue dispensers and, two respective slots and for collection of the laminations and formation of the lamination stack.
A system for wirelessly controlling a dressing interface for providing negative pressure therapy at a tissue site, the dressing interface including a housing having a therapy cavity and a component cavity separated by a wall, the system comprising: a circuit board forming a portion of the wall; a core module disposed on the circuit board and comprising: a sensor mounted on the circuit board and disposed within the therapy cavity, the sensor configured to collect physical parameter data indicative of physical properties of fluids from the tissue site; a processor mounted on the circuit board and disposed within the component cavity, the processor being coupled to the sensor and configured to read the physical parameter data from the sensor, a wireless transceiver mounted on the circuit board and disposed within the component cavity, the wireless transceiver being coupled to the processor and configured to communicate with a therapy device; and a first peripheral interface (2170, 2180) coupled to the core module by a high-speed bus and configured to communicate with the processor. a circuit board forming a portion of the wall; a core module disposed on the circuit board and comprising: a sensor mounted on the circuit board and disposed within the therapy cavity, the sensor configured to collect physical parameter data indicative of physical properties of fluids from the tissue site; a processor mounted on the circuit board and disposed within the component cavity, the processor being coupled to the sensor and configured to read the physical parameter data from the sensor, a wireless transceiver mounted on the circuit board and disposed within the component cavity, the wireless transceiver being coupled to the processor and configured to communicate with a therapy device; and a sensor mounted on the circuit board and disposed within the therapy cavity, the sensor configured to collect physical parameter data indicative of physical properties of fluids from the tissue site; a processor mounted on the circuit board and disposed within the component cavity, the processor being coupled to the sensor and configured to read the physical parameter data from the sensor, a wireless transceiver mounted on the circuit board and disposed within the component cavity, the wireless transceiver being coupled to the processor and configured to communicate with a therapy device; and a first peripheral interface (2170, 2180) coupled to the core module by a high-speed bus and configured to communicate with the processor.